Abstract
By means of glass bottle sampling followed by solid-phase microextraction gas chromatography-mass spectrometry (SPME-GC-MS) technique, the change characteristics of volatile organic compounds (VOCs) in breaths, between before gargling and after gargling, were investigated, respectively, in 41 healthy subjects and 50 esophageal cancer patients. Using an untargeted strategy, 143 VOC chromatographic peaks were enrolled in the statistical analysis. Based on the orthogonal partial least squares discriminant analysis (OPLS-DA), the VOC variations after gargling for each breath test group were obtained according to the combined criteria of variable importance in projection (VIP > 1.5), Wilcoxon signed-rank test (P < 0.05), and fold change (FC > 2.0). When gargled, the levels of indole, phenol, 1-propanol, and p-cresol in the breath of healthy people decreased; meanwhile, for esophageal cancer patients, the declined VOCs in breath were indole, phenol, dimethyl disulfide, and p-cresol. Particularly, these substances were previously reported as breath biomarkers in some diseases such as esophageal, gastric, thyroid, breast, oral, and lung cancers, as well as certain non-cancer disorders. The present work indicates that expiratory VOCs involve the prominent oral cavity source, and in the breath biomarkers study, the potential impact that originates from oral volatiles should be considered. In view of the present results, it is also proposed that gargle pretreatment could eliminate possible interference from the oral cavity VOCs that might benefit breath biomarker investigation.
Graphical abstract
Similar content being viewed by others
References
Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B, Yaghoobi M, Gurusamy KS. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Db Syst Rev. 2018;3(3):CD012080.
Harnan SE, Essat M, Gomersall T, Tappenden P, Pavord I, Everard M, Lawson R. Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review. Clin Exp Allergy. 2017;47(3):410–29.
Locatelli M, Tartaglia A, Ulusoy HI, Ulusoy S, Savini F, Rossi S, Santavenere F, Merone GM, Bassotti E, D'Ovidio C, Rosato E, Furton KG, Kabir A. Fabric-Phase sorptive membrane array as a noninvasive in vivo sampling device for human exposure to different compounds. Anal Chem. 2021;93(4):1957–61.
Kumar S, Huang J, Abbassi-Ghadi N, Španěl P, Smith D, Hanna GB. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem. 2013;85(12):6121–8.
Zou X, Zhou WZ, Lu Y, Shen CY, Hu ZT, Wang HZ, Jiang HH, Chu YN. Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry. J Gastroenterol Hepatol. 2016;31(11):1837–43.
Sun XH, Shao K, Wang T. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Anal Bioanal Chem. 2016;408(11):2759–80.
Wang TS, Pysanenko A, Dryahina K, Spaněl P, Smith D. Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res. 2008;2(3):037013.
Pereira JAM, Porto-Figueira P, Taware R, Sukul P, Rapole S, Câmara JS. Unravelling the potential of salivary volatile metabolites in oral diseases. A Review Molecules. 2020;25(13):3098.
Roslund K, Lehto M, Pussinen P, Groop PH, Halonen L, Metsälä M. On-line profiling of volatile compounds produced in vitro by pathogenic oral bacteria. J Breath Res. 2019;14(1):016010.
Li BZ, Zou X, Wang HM, Lu Y, Shen CY, Chu YN. Standardization study of expiratory conditions for on-line breath testing by proton transfer reaction mass spectrometry. Anal Biochem. 2019;581:113344.
Vadhwana B, Belluomo I, Boshier PR, Pavlou C, Španěl P, Hanna GB. Impact of oral cleansing strategies on exhaled volatile organic compound levels. Rapid Commun Mass Spectrom. 2020;34(9):e8706.
Lu Y, Niu WQ, Zou X, Shen CY, Xia L, Huang CQ, Wang HZ, Jiang HH, Chu YN. Glass bottle sampling solid phase microextraction gas chromatography mass spectrometry for breath analysis of drug metabolites. J Chromatogr A. 2017;1496:20–4.
Chu YJ, Zhou JJ, Ge DL, Lu Y, Zou X, Xia L, Huang CQ, Shen CY, Chu YN. Variable VOCs in plastic culture flasks and their potential impact on cell volatile biomarkers. Anal Bioanal Chem. 2020;412(22):5397–408.
Vietro DN, Aresta A, Rotelli MT, Zambonin C, Lippolis C, Picciariello A, Altomare DF. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results. J Pharm Biomed Anal. 2020;180:113055.
de Lacy CB, Amann A, Al-Kateb H, Flynn C, Filipiak W, Khalid T, Osborne D, Ratcliffe NM. A review of the volatiles from the healthy human body. J Breath Res. 2014;8(1):014001.
Milanowski M, Pomastowski P, Ligor T, Buszewski B. Saliva - volatile biomarkers and profiles. Crit Rev Anal Chem. 2017;47(3):251–66.
Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–24.
Van den Velde S, Nevens F, Van Hee P, van Steenberghe D, Quirynen M. GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Anal Technol Biomed Life Sci. 2008;875(2):344–8.
Codipilly D, Kleinberg I. Generation of indole/skatole during malodor formation in the salivary sediment model system and initial examination of the oral bacteria involved. J Breath Res. 2008;2(1):017017.
Imamura T. Influences of amino acids on the phenol and indole production of salivary microorganisms. Shigaku. 1982;70(1):21–35.
Bone E, Tamm A, Hill M. The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr. 1976;29(12):1448–54.
Saito Y, Sato T, Nomoto K, Tsuji H. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. Fems Microbiol Ecol. 2018;94(9):fiy125.
Claus D, Geypens B, Ghoos Y, Rutgeerts P, Ghyselen J, Hoshi K, Delanghe G. Oral malodor, assessed by closed-loop, gas chromatography, and ion-trap technology. J High Resol Chromatogr. 1997;20(2):94–8.
Turner C, Spanel P, Smith D. A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry. SIFT-MS. Physiol Meas. 2006;27(4):321–37.
Al-Kateb H, de Lacy CB, Ratcliffe N. An investigation of volatile organic compounds from the saliva of healthy individuals using headspace-trap/GC-MS. J Breath Res. 2013;7(3):036004.
Koureas M, Kirgou P, Amoutzias G, Hadjichristodoulou C, Gourgoulianis K, Tsakalof A. Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons. Metabolites. 2020;10(8):317.
van den Velde S, Quirynen M, van Hee P, van Steenberghe D. Halitosis associated volatiles in breath of healthy subjects. J Chromatogr B Anal Technol Biomed Life Sci. 2007;853(1-2):54–61.
Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta. 2004;347(1-2):25–39.
Van den Velde S, van Steenberghe D, Van Hee P, Quirynen M. Detection of odorous compounds in breath. J Dent Res. 2009;88(3):285–9.
Saad S, Hewett K, Greenman J. Effect of mouth-rinse formulations on oral malodour processes in tongue-derived perfusion biofilm model. J Breath Res. 2012;6(1):016001.
Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB, Ahn J. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77(23):6777–87.
Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, Lovat LB, Španěl P, Smith D, Hanna GB. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann Surg. 2015;262(6):981–90.
Markar SR, Wiggins T, Antonowicz S, Chin ST, Romano A, Nikolic K, Evans B, Cunningham D, Mughal M, Lagergren J, Hanna GB. Assessment of a noninvasive exhaled breath test for the diagnosis of oesophagogastric cancer. JAMA Oncol. 2018;4(7):970–6.
Adam ME, Fehervari M, Boshier PR, Chin ST, Lin GP, Romano A, Kumar S, Hanna GB. Mass-spectrometry analysis of mixed-breath, isolated-bronchial-breath, and gastric-endoluminal-air volatile fatty acids in esophagogastric cancer. Anal Chem. 2019;91(5):3740–6.
Hong Y, Che XX, Su HB, Mai ZB, Huang ZX, Huang WB, Chen W, Liu SL, Gao W, Zhou Z, Tan GB, Li X. Exhaled breath analysis using on-line preconcentration mass spectrometry for gastric cancer diagnosis. J Mass Spectrom. 2021;56(4):e4588.
Lamote K, Brinkman P, Vandermeersch L, Vynck M, Sterk PJ, Van Langenhove H, Thas O, Van Cleemput J, Nackaerts K, van Meerbeeck JP. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study. Oncotarget. 2017;8(53):91593–602.
Guo L, Wang CS, Chi CJ, Wang XY, Liu SS, Zhao W, Ke CF, Xu GW, Li EY. Exhaled breath volatile biomarker analysis for thyroid cancer. Transl Res. 2015;166(2):188–95.
Zhang Y, Guo L, Qiu ZZ, Lv Y, Chen GM, Li EY. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: a prospective cohort study. J Clin Lab Anal. 2020;34(12):e23526.
Di Gilio A, Catino A, Lombardi A, Palmisani J, Facchini L, Mongelli T, Varesano N, Bellotti R, Galetta D, de Gennaro G, Tangaro S. Breath analysis for early detection of malignant pleural mesothelioma: volatile organic compounds (VOCs) determination and possible biochemical pathways. Cancers. 2020;12(5):1262.
Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer. 2009;9:348.
Rudnicka J, Kowalkowski T, Ligor T, Buszewski B. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879(30):3360–6.
Ulanowska A, Kowalkowski T, Trawińska E, Buszewski B. The application of statistical methods using VOCs to identify patients with lung cancer. J Breath Res. 2011;5(4):046008.
Buszewski B, Ulanowska A, Kowalkowski T, Cieśliński K. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Clin Chem Lab Med. 2012;50(3):573–81.
Ma HY, Li X, Chen JM, Wang HJ, Cheng TT, Chen K, Xu SF. Analysis of human breath samples of lung cancer patients and healthy controls with solid-phase microextraction (SPME) and flow-modulated comprehensive two-dimensional gas chromatography (GC × GC). Anal Methods. 2014;6(17):6841.
Rudnicka J, Walczak M, Kowalkowski T, Jezierski T, Buszewski B. Determination of volatile organic compounds as potential markers of lung cancer by gas chromatography–mass spectrometry versus trained dogs. Sens Actuators B. 2014;202:615–21.
Sakumura Y, Koyama Y, Tokutake H, Hida T, Sato K, Itoh T, Akamatsu T, Shin W. Diagnosis by volatile organic compounds in exhaled breath from lung cancer patients using support vector machine algorithm. Sensors. 2017;17(2):287.
Hartwig S, Raguse JD, Pfitzner D, Preissner R, Paris S, Preissner S. Volatile organic compounds in the breath of oral squamous cell carcinoma patients: a pilot study. Otolaryngol Head Neck Surg. 2017;157(6):981–7.
Dadamio J, Van den Velde S, Laleman W, Van Hee P, Coucke W, Nevens F, Quirynen M. Breath biomarkers of liver cirrhosis. J Chromatogr B Anal Technol Biomed Life Sci. 2012;905:17–22.
Martinez-Lozano Sinues P, Meier L, Berchtold C, Ivanov M, Sievi N, Camen G, Kohler M, Zenobi R. Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease. Respiration. 2014;87(4):301–10.
Gaida A, Holz O, Nell C, Schuchardt S, Lavae-Mokhtari B, Kruse L, Boas U, Langejuergen J, Allers M, Zimmermann S, Vogelmeier C, Koczulla AR, Hohlfeld JM. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. J Breath Res. 2016;10(2):026006.
Acknowledgements
This research was supported by the National Natural Science Foundation of China (No. 21876176, 21777163, 21477132, 81401756, 21705152, 22076190); the Youth Innovation Promotion Association, Chinese Academy of Sciences (2019432); the President Foundation of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (YZJJZX202009); the Joint Fund between the Second Affiliated Hospital of Anhui Medical University and the Center of Medical Physics and Technology of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (LHJJ2020006); the Key Program of 13th Five Year Plan, CASHIPS (KP-2017-25); and the Anhui Provincial Key R&D Program (202104d07020003).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
This breath test project passed the check by the Ethical Committee of the Hefei Institutes of Physical Science, Chinese Academy of Science (approval number: Y-2019-19). All the gargle and breath tests were conducted after informed consent by the cancer patients and their accompanying family members as healthy subjects.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ge, D., Zhou, J., Chu, Y. et al. Distinguish oral-source VOCs and control their potential impact on breath biomarkers. Anal Bioanal Chem 414, 2275–2284 (2022). https://doi.org/10.1007/s00216-021-03866-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-021-03866-8